New Research Report - MST Access, page-11

I appreciate your updates and research. I would pay little attention to some of these posters who seem to have made accounts for the sole reason of commenting on threads for which they have no holdings or no interest in a sensible discussion. Like it or not, we are where we are. A refocusing of attention on TAVR and potential for partnership following these in human trials is exciting. I accept that we might not get there. That’s a risk in all Co’s working towards commercialisation of a novel product. But surely it’s worth riding it out from here! Here’s hoping for some progress and in the meantime some sensible discussion on here.